Transition Bio
About:
Transition Bio provides condensate technology for drug discovery and diagnostics.
Website: https://www.transitionbio.com/
Top Investors: Bristol-Myers Squibb, Northpond Ventures, Taiho Ventures, Lifeforce Capital, Magnetic Ventures
Description:
Transition Bio provides condensate technology for drug discovery and diagnostics. The company focuses on the discovery, analysis, and modulation of biological condensates, propelled by a differentiated technological capability that generates expansive drug development opportunities in a hypothesis-free manner.
$63.3M
Cambridge, Massachusetts, United States
2020-01-01
David Weitz, Peter St George-Hyslop, Sarah Teichmann, Tuomas Knowles
11-50
2024-10-24
Private
© 2025 bioDAO.ai